U.S. regulators have authorized a second pill against COVID-19, an antiviral drug from Merck that may help blunt the wave of infections driven by the omicron variant.
Ahead of the Christmas holiday, officials are scrambling to combat the fast spreading omicron variant. This comes as the FDA issues emergency use authorization for Pfizer’s COVID-19 treatment pill.
The U.S. has authorized the first pill against COVID-19, a Pfizer drug that Americans can take at home to reduce the risk of hospitalization and death.
DHEC reports 570 hospital beds filled with COVID-19 patients this evening, 23% higher than a week ago.
Final data on Pfizer’s experimental treatment for COVID-19 has now been shared with the FDA. It’s part of the company’s application to authorize the pill for emergency use.
Another potential weapon in the fight against COVID-19 could soon be on the way, with drugmaker Merck releasing promising data on a new treatment for the virus.
Prisma Health is administering the monoclonal antibody treatment to high-risk COVID-19 patients in the Midlands and the Upstate.
The Food and Drug Administration has sent warning letters to companies selling products that falsely claim to treat COVID-19.
The United States Food and Drug Administration is authorizing Regeneron’s antibody cocktail for some patients who test positive for COVID-19.
As COVID-19 cases continue to climb here in the U.S., the FDA has just approved Remdesivir to treat coronavirus patients, though it was only used in hospitals in cases of emergency.
